Major Investment from Genome Canada to Help Advance ClarityDX Prostate Adoption Across Canada
The funding to propel widespread adoption and integration of innovative prostate cancer diagnostic test into Canadian healthcare.
June 26, 2025
A Digital Publication for the Practicing Medical Specialist, Industry Executive, & Investor
The funding to propel widespread adoption and integration of innovative prostate cancer diagnostic test into Canadian healthcare.